Brief: Castle Biosciences Reports Fourth Quarter And Full-Year 2022 Results

Castle Biosciences

28/02/2023 22:24

Feb 28 (Reuters) - Castle Biosciences Inc  CSTL.O :
    * CASTLE BIOSCIENCES REPORTS FOURTH QUARTER AND FULL-YEAR
2022
RESULTS
    * FULL-YEAR 2023 REVENUE IS EXPECTED TO BE BETWEEN $170
MILLION-180 MILLION
    * QTRLY LOSS PER SHARE, BASIC AND DILUTED $ 0.78
    * Q4 EARNINGS PER SHARE VIEW $-0.84, REVENUE VIEW $37.2
MILLION --
REFINITIV IBES DATA
    * FY2023 REVENUE VIEW $168.3 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw31Jcpba 
Further company coverage:  CSTL.O 

 ((Reuters.Briefs@thomsonreuters.com;))